Ocugen signs term sheet for korean licensing of OCU400 gene therapy
OCU400 is Ocugen’s novel modifier gene therapy for retinitis pigmentosa (RP).
Related Articles
HOYA Vision Care acquires Canadian distributor Centennial Optical
Centennial Optical distributes ophthalmic frames, eyeglass lenses, sunglasses, lab supplies, and optical accessories.
Where We Exhibit – American Academy of Ophthalmology
Listings for all local, national and international meetings, conferences and where the Academy exhibits
Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapy
Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, offering reduced risks and improved outcomes.
Week in Review: Transient Visual Disturbances During Pregnancy, Pandemic-Related Increases in Astigmatism, Ophthalmology Referral Rates for Patients With Diabetes
Increases in transient visual disturbances are seen during pregnancy, the COVID-19 pandemic may have increased the risk of astigmatism, and certain factors could contribute to…
Diagnosis of Primary Open-Angle Glaucoma and Mental Health Status
This cohort study examines whether a diagnosis of primary open-angle glaucoma in patients with ocular hypertension is associated with a decrease in mental health.
GLP-1 Receptor Agonists Linked to Increased nAMD Risk
A recent population-based cohort study has identified a significant association between the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and an increased risk of developing…
Ocular Surgery News U.S. Edition – Healio
Read articles appearing in the print edition of Ocular Surgery News U.S. Edition. Healio is your trusted source for medical news.
ViGeneron rebrands as VeonGen Therapeutics, announces rare pediatric disease designation for VG801
VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for…
Where We Exhibit – American Academy of Ophthalmology
Listings for all local, national and international meetings, conferences and where the Academy exhibits
3 Things You Should Know About Interventional Glaucoma Comanagement
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.